Table 1.
Variable | Non-tuberculosis N = 9422 | Tuberculosis N = 9422 | P-value* | ||
---|---|---|---|---|---|
n | % | n | % | ||
Sex | 0.88 | ||||
Female | 3,000 | 31.8 | 3,010 | 31.9 | |
Male | 6,422 | 68.2 | 6,412 | 68.1 | |
Age group (years) | 0.99 | ||||
20–39 | 1,551 | 16.4 | 1,549 | 16.4 | |
40–64 | 3,474 | 36.9 | 3,472 | 36.9 | |
65–84 | 4,397 | 46.7 | 4,401 | 46.7 | |
Age (years), mean (standard deviation)† | 59.5 | (17.1) | 59.6 | (17.1) | 0.8 |
Duration of exposure to proton pump inhibitors (months), mean (standard deviation)† | 3.49 | (6.06) | 3.19 | (5.96) | 0.13 |
Ever use of proton pump inhibitors | 1,694 | 18 | 2,102 | 22.3 | <0.001 |
Ever use of histamine-2 receptor antagonists | 371 | 3.94 | 346 | 3.67 | 0.34 |
COMORBIDITIES | |||||
Alcohol-related disease | 717 | 7.61 | 745 | 7.91 | 0.45 |
Asbestosis | 1 | 0.01 | 1 | 0.01 | 0.99 |
Chronic liver disease | 1,637 | 17.4 | 1,674 | 17.8 | 0.48 |
Chronic obstructive pulmonary disease | 4,111 | 43.6 | 4,136 | 43.9 | 0.71 |
Chronic kidney disease | 459 | 4.87 | 468 | 4.97 | 0.76 |
Diabetes mellitus | 1,433 | 15.2 | 1,477 | 15.7 | 0.38 |
Human immunodeficiency virus infection | 21 | 0.22 | 21 | 0.22 | 0.99 |
Gastrectomy | 9 | 0.1 | 9 | 0.1 | 0.99 |
Pneumoconiosis | 87 | 0.92 | 75 | 0.80 | 0.34 |
Splenectomy | 2 | 0.02 | 2 | 0.02 | 0.99 |
Data are presented as the number of subjects in each group with percentages given in parentheses, or mean with standard deviation given in parentheses.
Chi-square test, and
t-test comparing subjects with and without pulmonary tuberculosis.